A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma

The benefits of adjuvant cytokine-induced killer (CIK) cell immunotherapy for hepatocellular carcinoma (HCC) remain mixed among patients. Here, we constructed a prognostic nomogram to enable individualized predictions of survival benefit of adjuvant CIK cell treatment for HCC patients. Survival anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qiu-Zhong, Wang, Qi-Jing, Dan, Jia-Qiang, Pan, Ke, Li, Yong-Qiang, Zhang, Yao-Jun, Zhao, Jing-Jing, Weng, De-Sheng, Tang, Yan, Huang, Li-Xi, He, Jia, Chen, Shi-Ping, Ke, Miao-La, Chen, Min-Shan, Wicha, Max S., Chang, Alfred E., Zeng, Yi-Xin, Li, Qiao, Xia, Jian-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361845/
https://www.ncbi.nlm.nih.gov/pubmed/25776856
http://dx.doi.org/10.1038/srep09202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361845/
https://www.ncbi.nlm.nih.gov/pubmed/25776856
http://dx.doi.org/10.1038/srep09202

Ejemplares similares